Quantitative Profiling of DNA Damage Response Proteins Using iTRAQ Labeling and the LTQ Orbitrap XL

Importance of the Topic

The DNA damage response pathway maintains genomic stability by orchestrating phosphorylation-driven signaling. Understanding protein dynamics after DNA damage supports cancer research and therapeutic development.

Goals and Study Overview

This study quantified DNA damage response proteins in A549 lung carcinoma cells at 0, 2, 8, and 24 hours after camptothecin treatment. iTRAQ labeling combined with high-resolution LTQ Orbitrap XL mass spectrometry and HCD fragmentation enabled time-resolved profiling.

Methodology

A549 cells were treated with 5 μM camptothecin and harvested at four time points. Whole-cell lysates and phosphoprotein-enriched fractions were prepared using protease/phosphatase inhibitors, acetone precipitation, tryptic digestion, and individual iTRAQ labeling (114–117). Labeled samples were pooled, cleaned by C18 spin columns, and phosphopeptides enriched via IMAC. Nano-LC separation preceded analysis on an LTQ Orbitrap XL operated in parallel HCD and CID modes. Data were processed using SEQUEST, Mascot, and Proteome Discoverer against the human IPI database. Reporter ion ratios were normalized to α-tubulin and filtered by statistical significance (p<0.05).

Instrumentation Used

• LTQ Orbitrap XL with HCD cell and nanospray ion source
• NanoLC-2D system with PepMap C18 column
• Thermo Scientific Phosphoprotein Enrichment Kit and IMAC spin columns

Results and Discussion

Analysis of whole lysates identified 539 proteins; phospho-enrichment detected 303, adding 145 unique proteins and raising kinase content from 0.5% to 4%. Proteome changes peaked at 8 hours, with predominant up-regulation in whole lysate and down-regulation in enriched samples. Site-specific phosphopeptide quantitation revealed dynamic regulation of p53 Ser15, HMGA1, and a novel site on RNA polymerase II coactivator p15. Sequential IMAC enrichment of 15 μg sample added 30 phosphorylation site identifications.

Benefits and Practical Applications

• High-resolution, multiplexed quantitation of proteins and phosphosites in complex samples
• Enhanced phosphoproteome coverage through sequential enrichment strategies
• Informative time-course profiling for drug response characterization and biomarker discovery

Future Trends and Applications

Advances in high-resolution MS instruments and enrichment chemistries will further improve sensitivity for low-abundance phosphopeptides. Integration with targeted quantitation and computational network analysis will expand applications in precision medicine and systems biology.

Conclusion

iTRAQ labeling combined with HCD-enabled nanoLC-MS/MS on an LTQ Orbitrap XL delivers robust and precise quantitation of DNA damage response proteins and phosphorylation dynamics. The described enrichment workflow enhances identification depth and provides insights into time-dependent signaling events.

Reference

1. Ashcroft M. et al. Regulation of p53 function and stability by phosphorylation. Mol. Cell Biol. 1999, 19(3):1751–1758.
2. Saito S. et al. Phosphorylation site interdependence of human p53 post-translational modifications. J. Biol. Chem. 2003, 278(39):37536–37544.
3. Zhang T., Viner R., Zabrouskov V. Quantitation of iTRAQ labeled peptides using HCD on the LTQ Orbitrap. Thermo Fisher Appl. Note #421.
4. Matsuoka S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316(5828):1160–1166.
5. Jonker H.R.A. et al. Gradual phosphorylation regulates PC4 coactivator function. FEBS J. 2006, 273(7):1430–1444.